Ruth Greferath
Geen lopende functies
Loopbaan van Ruth Greferath
Eerdere bekende functies van Ruth Greferath
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AC IMMUNE SA | Oprichter | 13-02-2003 | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Oprichter | 03-08-2009 | - |
| Corporate Officer/Principal | 31-07-2009 | - |
Opleiding van Ruth Greferath
| Yeshiva University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Zwitserland | 2 |
Operationeel
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Beurs
- Insiders
- Ruth Greferath
- Ervaring
